linjc16/ctgov huggingface dataset:
COVID-19 Pandemic and Academic Performance of Veterinary Students

Study Overview
=================
Brief Summary
-----------------
The study aims to analyze the effect of COVID-19 pandemic on the academic performance of veterinary students, veterinarians, and researchers during the lockdown.

Official Title
-----------------
The Impact of COVID-19 Pandemic on the Academic Performance of Veterinary Medical Students and Researchers

Conditions
-----------------
COVID-19

Intervention / Treatment
-----------------
* Other: survey


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Veterinary students and researchers Exclusion Criteria: -

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 60 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Veterinary students and researchers<br> | Other: survey<br>* online survey<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Measure the effect of COVID-19 pandemic on the academic performance of veterinary medical students | An online questionnaire (Question:How did COVID-19 pandemic affect your study/ research?. Response: Greatly affected, Moderately affected, slightly affected, Not affected | 13/4/2020 - 10/8/2020 | 
| Measure the average studying time | Open question: How many hours do you spend in on-line learning? | 13/4/2020 - 10/8/2020 | 
| Evaluate on-line education during COVID-19 pandemic lockdown | Question:How do you rate on-line education? Answer on 1-10 scale, 1 is the lowest evaluation and 10 is the highest evaluation | 13/4/2020 - 10/8/2020 | 
| Evaluate on-line education in practical lessons during COVID-19 pandemic lockdown | Question:How do you rate on-line education in practical lessons? Answer on 1-10 scale, 1 is the lowest evaluation and 10 is the highest evaluation | 13/4/2020 - 10/8/2020 |
Follow-up of Recovery Condition in Survivors of Acute Respiratory Distress Syndrome

Study Overview
=================
Brief Summary
-----------------
Hope to realize the recovery condition of ARDS survivors in Taiwan. It would be helpful not only to design the proper rehabilitation program but also to be a useful reference for the poor recovery patients to take hospice care if indicated.

Detailed Description
-----------------
This study will enroll the participant met the diagnostic criteria of ARDS. The basic data, clinical manifestations, laboratory data and outcomes of participants will be recorded. And the investigator will also follow up the pulse oximeter, peak expiratory flow rate, six-minute walk test and health-related quality of life measures with SF-36 in 3, 6 and 12 months after the participants were discharged from the ICU. Through this study, the investigator hope to realize the recovery condition of ARDS survivors in Taiwan. It would be helpful not only to design the proper rehabilitation program but also to be a useful reference for the poor recovery patients to take hospice care if indicated.

Official Title
-----------------
Follow-up of Recovery Condition in Survivors of Acute Respiratory Distress Syndrome

Conditions
-----------------
Mortality

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: ARDS patients Exclusion Criteria: NA

Ages Eligible for Study
-----------------
Minimum Age: 20 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| occurrence of postextubation stridor | To determine whether treatment with corticosteroids decreases the incidence of postextubation airway obstruction in an adult intensive care unit. | 24 hours | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| The actual tidal volume at expiration | The actual tidal volume at expiration was measured before and after deflation of the endotracheal tube cuff as previously described (9). The difference in the actual tidal volume before and after cuff deflation was defined as the cuff leak volume (CLV). | 24 hours |
TREatment of Uretral STRICTure With Self-catheterization : Tolerance Evaluation

Study Overview
=================
Brief Summary
-----------------
Urethral stenosis has a recurrent character. The clean intermittent self-catheterization can be proposed for repeat stenosis. This study seeks to explore the tolerance of clean intermittent self-catheterization in the evolution of urethral stenosis after urethrotomy.

Official Title
-----------------
TREatment of Uretral STRICTure With Self-catheterization : Tolerance Evaluation

Conditions
-----------------
First or Second Uretral Stenosis, Diagnosed With Uretral Fibroscopy

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion criteria: Men between 18 and 80 First or second uretral stenosis, diagnosed with uretral fibroscopy Exclusion criteria: Not multiple, strength or long stenosis No previous surgery of the urethra Refusal to participate to the study Inability to perform self-catheterization

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of patient which continue clean intermittent self-catheterization. | Evaluation of patients tolerance with clean intermittent self-catheterization | 18 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Comparaison of uroflowmetry | Evaluation of patients urinary profile | 18 months | 
| Comparaison of Urinary Score Profile (USP) | Evaluation of patients quality of life | 18 months |
Validity and Reliability of Perceived Exertion Rating Scale in Children With Brain Damage

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to examine the reliability and validity of the rating of perceived exertion scale in children post severe traumatic brain injury during treadmill exercise.

Detailed Description
-----------------
walking on a treadmill twice- one weeks interval five intensity level in each session

Official Title
-----------------
Validity and Reliability of Perceived Exertion Rating Scale in Children With Traumatic Brain Injury, Cerebral Palsy and Typically Developed

Conditions
-----------------
Traumatic Brain Injury, Cerebral Palsy

Intervention / Treatment
-----------------
* Other: Walking on treadmill, different velocities and incline


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Children post severe closed head injury (Glasgow Coma Scale [GCS] score at admission to emergency room of ≤8, at least one year post trauma Ages 7 to 12 years (3) independent ambulation (foot orthoses permitted). Children with Cerebral palsy, GMFCS 1 or 2, ages 7 to 12 years. Typically developed controls. Exclusion criteria: Cannot understand simple instructions

Ages Eligible for Study
-----------------
Minimum Age: 7 Years
Maximum Age: 12 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| all participants<br>Walking on treadmill, different velocities and incline | Other: Walking on treadmill, different velocities and incline<br>* Walking on treadmill twice, with one week interval in each session the child will walk in different velocities and incline<br>* Other names: RPE;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| OMNI scale, a pictorial perceived extortion scale for children |  | three meetings once a week. |
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache

Study Overview
=================
Brief Summary
-----------------
This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.

Conditions
-----------------
Migraine Disorders, Headache

Intervention / Treatment
-----------------
* Other: No Intervention


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months Eight (8) headache days per month for at least 1 of the preceding 15 months Exclusion Criteria: Not currently diagnosed with chronic migraine, headache or migraine History of receiving botulinum toxin injections for the treatment of chronic migraine.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Chronic Migraine Diagnosis<br>This is a retrospective chart review for patients diagnosed with Chronic Migraine. There is no intervention in this study. | Other: No Intervention<br>* There is no intervention in this study.<br>|
| Other Headache Diagnoses<br>This is a retrospective chart review of patients with headache diagnoses other than Chronic Migraine. There is no intervention in this study. | Other: No Intervention<br>* There is no intervention in this study.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Presence or Absence of Prophylactic Medication for Headache/Migraine | The presence or absence of prophylactic medications used by the subject for headache/migraine is evaluated through the study period. | 15 Months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of Unique Prophylactic Medications for Headache/Migraine Reported | The numbers of unique prophylactic medications used by the subjects for headache/migraine are evaluated through the study period. | 15 Months | 
| Number of Days With a Headache Recorded at the Visit With the Highest Number of Headaches | The number of headache days is reported at the visit with the highest number of headaches. | 15 Months | 
| Highest Number of Headache Days Per Month at a Qualifying Visit | The highest number of headache days per month are reported at a qualifying visit per the medical record. | 15 Months | 
| Number of Visits for Headache Diagnosis | The number of visits for headache diagnosis is evaluated through the study period. | 15 Months |
Can the Usage of Regional Block Room Save the Time of Anesthesia Team

Study Overview
=================
Brief Summary
-----------------
Study of time usage of anesthesia team inside the main operating room compares between 2 groups of Performing regional anesthesia inside the operating room Performing regional anesthesia in the block room Study purpose: How much will the investigators save time in the main operating room if we perform the regional anesthesia in the block room?

Detailed Description
-----------------
Anesthesia-controlled time means anesthesia pre-procedure time plus anesthesia post-procedure time. We also compares the anesthesia-controlled time in 3 groups of general anesthesia regional anesthesia general anesthesia combined with regional anesthesia

Official Title
-----------------
Can the Usage of Regional Block Room Save the Time of Anesthesia Team in the Main Orthopedic Operating Room?

Conditions
-----------------
Anesthesia, Time

Intervention / Treatment
-----------------
* Procedure: regional anesthesia


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: elective orthopedic surgical patients that require for anesthesia ( start 9AM-4PM) Exclusion Criteria: surgery under local infiltration

Ages Eligible for Study
-----------------
Minimum Age: 1 Month

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| RA in block room<br>Performing regional anesthesia in the block room | Procedure: regional anesthesia<br>* regional anesthesia procedure<br>* Other names: peripheral nerve block;|
| RA inside OR<br>Performing regional anesthesia inside the main orthopedic operating room | Procedure: regional anesthesia<br>* regional anesthesia procedure<br>* Other names: peripheral nerve block;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| anesthesia-controlled time | anesthesia-controlled time = anesthesia pre-procedure time + anesthesia post-procedure time | 3 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| turnover time | turnover time = time new patient-in minus previous patient-out | 3 months | 
| number of elective cases after 4PM | number of the elective cases that will be running after 4 PM | 3 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
anesthesia-controlled time, turnover time
A Modified Omental Patch Work Decreases Pancreatic Fistula After Lpd

Study Overview
=================
Brief Summary
-----------------
Pancreaticoduodenecotmy(PD) is considered as the standard procedure for peri-amplullary or pancreatic head tumors. Laparoscopic pancreaticoduodenctomy(LPD) has been reported with minimal invasive advantages, such as small incision, less blood loss, less pain, et al. Further, some trials showed LPD got less morbidity and shorter length of stay. Pancreatic fistula is the major complication for pancreaticodupdenectomy and associated with numerous serious complications, suffering reoperation or sometimes death. The reported rate was 10% to 55%. A lot of modified procedure have been proposed to reduce pancreatic fistula. Omental flaps around anastomosis have been used to prevent post pancreaticoduodenectomy fistula or hemorrhage. However, the outcomes are controversy. A modified omental patch work has been used during LPD and the initial outcomes are good. This is a pilot study to evaluate the function of the modified omental patch work on decreasing the pancreatic fistula.

Official Title
-----------------
A Modified Omental Patch Work Decreases Pancreatic Fistula After Laparoscopic Pancreaticoduodenectomy

Conditions
-----------------
Omental Patch, Laparoscopic Pancreaticoduodenectomy, Pancreatic Fistula

Intervention / Treatment
-----------------
* Other: omental patchwork


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: . Disease of periampullary or pancreatic head tumor . Age: 18 years or older Distant metastases are not diagnosed preoperatively. . Patients who can provide written informed consent Exclusion Criteria: . Patients with severe organ disease such as cardiac disease,respiratory illness . Patients with extended LPD or vessels reconstruction Patients with conversion to laparotomy . Patients with pregnancy

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: omental patchwork group<br> | Other: omental patchwork<br>* the omental flaps were sewn to lesser omentum and hepatorenal ligament to cover all the vessels<br>|
| No Intervention: non-omental patchwork group<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| pancreatic fistula | Incidence of pancreatic fistula grade B/C defined by ISGPF classification | 90 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| morbidity |  | 90 days | 
| Mortality |  | 90 days | 
| Postoperative hospital stay |  | 90 days |
A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy

Study Overview
=================
Brief Summary
-----------------
The primary objective of this study was to establish the long-term tolerability and safety of istradefylline treatment in subjects with Parkinson's disease treated with levodopa/carbidopa. In addition, treatment response and maintenance of response were assessed.

Official Title
-----------------
A Long-Term, Multicenter, Open-Label, Safety Study With a Flexible Dose Range of KW-6002 as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy

Conditions
-----------------
Parkinson's Disease

Intervention / Treatment
-----------------
* Drug: istradefylline


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Eligible subjects were: male or female at least 30 years of age had completed participation in a prior double-blind istradefylline trial met United Kingdom's Parkinson's Disease Society (UKPDS) brain bank criteria (Step 1 and Step 2) for Parkinson's disease and the severity of the Parkinson's disease was defined as Stages 2-4 on the Modified Hoehn and Yahr Scale while in the OFF state had been treated with levodopa for at least 1 year had been on a stable Parkinson's disease regimen within normal therapeutic ranges including levodopa for at least 4 weeks before Baseline were currently taking at least 4 doses of levodopa per day (3 doses per day if at least 2 doses contained slow-release formulation) had predictable end-of-dose wearing-off Exclusion Criteria: none

Ages Eligible for Study
-----------------
Minimum Age: 30 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: istradefylline<br> | Drug: istradefylline<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
long-term tolerability and safety, istradefylline treatment, levodopa/carbidopa
Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2

Study Overview
=================
Brief Summary
-----------------
To evaluate the incidence of patients with a positive test for SARS-CoV-2, performed in the preoperative screening for patients treated at the institution

Detailed Description
-----------------
Cohort, prospective, observational study to evaluate the incidence of asymptomatic patients with a positive SARS-CoV-2 test detected in the preoperative screening program of the institution.

Official Title
-----------------
Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2

Conditions
-----------------
SARS-CoV-2, Oncology, Surgery

Intervention / Treatment
-----------------
* Diagnostic Test: PT-PCR test for SARS-CoV-2


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients with elective surgery scheduled at the IBCC, including those diagnosed with any type of cancer; Patients who will undergo the screening test for SARS-COV-2 by RT-PCR (nasal swab), according to the guidelines and protocol of the hospital Exclusion Criteria: Urgent or emergency surgery; Screening test for SARS-COV-2 not performed Incomplete data in the institutional database

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients tested for SARS-CoV-2<br>Patients who underwent the preoperative screening program for SARS-CoV-2 | Diagnostic Test: PT-PCR test for SARS-CoV-2<br>* Screening test for the diagnosis of SARS-CoV-2 in asymptomatic patients<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program | Describe the incidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program in our center | May- December 2020 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of SARS-CoV-2 infection in the postoperative period in patients with negative screening test; | Describe the incidence of SARS-CoV-2 infection in the postoperative period in patients with negative screening test. | Up to 30 days | 
| Postoperative complications | Postoperative complications will be recorded, according to the Clavien-Dindo classification. | Up to 30 days | 
| Mortality | To evaluate the risk of all-cause mortality | 30 days | 
| Delay in the cancer treatment | Assess the impact of delayed cancer treatment | May 2020- March 2021 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
SARS-CoV-2, Surgical Oncology, PT-PCR Screening Test